Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
Gonzalez-Lama Y, Fernandez-Blanco I, Lopez-SanRoman A, Taxonera C, Casis B, Tabernero S, Bermejo F, Martinez-Silva F, Mendoza JL, Martinez-Montiel P, Carneros JA, Sanchez F, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid.
Gonzalez-Lama Y, et al. Among authors: taxonera c.
Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1609-14.
Hepatogastroenterology. 2008.
PMID: 19102352